Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eahMCduTtWCfewAyCidncVCicNlqFI
- FDA expands approval of GSK-Ligand's platelet drug Promacta
The FDA approved GlaxoSmithKline and Ligand Pharmaceuticals' Promacta, or eltrombopag, to treat low platelet count in people with hepatitis C, so they can receive standard treatment. The approval is the first for supportive care to help patients unsuited for interferon-based therapy because of low platelet counts. Reuters (11/19)        | Complimentary Webinar - Simplifying the Audit Management Process
Tuesday, November 27, 2012, 11:00 am Eastern
Join us to hear how the new TrackWise Audit Execution Package Bundle drives efficiency through enhanced TrackWise capabilities, advanced services and training. Learn how the TrackWise Audit Execution Package can improve productivity, reduce costs and streamline your audit processes in the most effective manner. Register Now! | |
| Health Care & Policy |  |  | | - Celgene's myeloma drug pomalidomide improves survival in trial
Patients with multiple myeloma who received Celgene's pomalidomide plus low-dose dexamethasone lived significantly longer and had greater progression-free survival than those who received high-dose dexamethasone alone during a trial. An FDA review of the drug is expected to be completed by Feb. 10. Reuters (11/19)  | Two courses in four days at MIT Sloan Exec Ed
Learn from world-renowned faculty at MIT Executive Education and make the most of your visit with back-to-back two-day courses. Understand big data, revitalize your digital business model, solve complex business problems, drive strategic innovation. View 25+ short courses. |
 | Global Developments | | | | - Living Cell Technologies to start human Ntcell trial
New Zealand's health regulators have given the go-ahead for Living Cell Technologies' early-stage clinical study of its Ntcell treatment for Parkinson's disease. The first human trial for the treatment is slated to start early next year. The therapy includes the transplantation of animal choral plexus cells into the brain to restore nerves. Australian Life Scientist (11/16) | Food & Agriculture | | | | | Industrial & Environmental | | | | - BIO hails EPA's decision to deny RFS waiver requests
BIO and other ethanol groups praised the Environmental Protection Agency's decision to reject the requests for a temporary waiver of the Renewable Fuel Standard. The decision to uphold RFS would protect the country's energy security and support advances in commercializing production of advanced biofuels, said BIO Executive Vice President Brent Erickson. "This decision allows BIO member companies to continue to deliver innovative technologies to the market to expand our domestic production of biofuels, including fuels from agricultural residues, municipal solid waste, algae and purpose grown energy crops," he said. EthanolProducer.com (11/16) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | A good man with a good conscience doesn't walk so fast."
--Georg Büchner,
German writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, November 19, 2012
- Friday, November 16, 2012
- Thursday, November 15, 2012
- Wednesday, November 14, 2012
- Tuesday, November 13, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment